about
Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects.Novel serial positive enrichment technology enables clinical multiparameter cell sortingVaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.Total nodal irradiation in patients with severe treatment-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation: Response rates and immunomodulatory effects.High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity.Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease.Isolation of intact genomic DNA from FOXP3-sorted human regulatory T cells for epigenetic analyses.Driving allotolerance: CAR-expressing Tregs for tolerance induction in organ and stem cell transplantation.Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host diseaseA promoter-level mammalian expression atlasBioluminescence imaging of lymphocyte trafficking in vivo.Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.Advancing animal models of neoplasia through in vivo bioluminescence imaging.Evaluation of effector cell fate and function by in vivo bioluminescence imaging.A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cellsAltered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.CD4+CD25+ regulatory T cells and graft-versus-host disease.Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.Regulatory mechanisms in graft-versus-host responses.Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation.Regulatory T cells for the prevention of graft-versus-host disease: professionals defeat amateurs.Regulatory T cells in stem cell transplantation: strategies and first clinical experiences.The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations.Physiologic TLR9-CpG-DNA interaction is essential for the homeostasis of the intestinal immune system.FANTOM5 CAGE profiles of human and mouse samplesLangerhans cells promote early germinal center formation in response to Leishmania-derived cutaneous antigens.Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease.Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome.Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.Basophils inhibit proliferation of CD4⁺ T cells in autologous and allogeneic mixed lymphocyte reactions and limit disease activity in a murine model of graft versus host disease.TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation.Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection.The impact of a tumor diagnosis on patients' attitudes toward advance directives.Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression.Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naïve Treg.
P50
Q27301956-902D02BA-418F-4057-9DC5-3F90945842C6Q28730418-E772F87E-1E7D-4BCC-AF23-763A2070473FQ30408740-8E2DD302-FA72-41A8-AEF2-896F7F947FC1Q33425047-490A5E5A-0197-46CA-BD35-8512FB73966CQ33434270-DFDA9DC1-D4BD-4E69-BA1F-EAAFA85F4F36Q33459679-ED483BAA-DFB5-4BF9-8183-7EA24CA537B2Q33466454-24689CD5-A585-46D1-891F-5143C7D76988Q33536675-5792B49F-F64D-4526-9232-47153040BA41Q34046493-1965F7DE-046F-4736-8F39-A6132F73ACDDQ34089511-8AB1E5E2-E72C-4BC8-A67F-FACE122EF405Q34412203-2128D589-9AED-462D-AD96-FFFFF665F63AQ34466455-926F86A3-F5DB-4AA7-A2AF-5E90C43E08C1Q34572954-624EA90A-649E-403E-8054-D6BEE967A044Q34975006-F086432A-4A2E-4D5E-A9D3-A75048121486Q35212689-96C081F7-E0B7-44BC-9531-071F6AF12B26Q35743874-1B00294A-D059-47A2-A15D-3CCCC8085C45Q36220347-6CD135F7-525C-44ED-B31D-1547414E1698Q36368127-2BA9D019-00ED-4453-AAD0-14239CA0A66FQ36650103-803A0BA4-504D-4336-A03D-B2880A5D2376Q37152028-97DA928E-5848-467B-9458-7A7DDBA045E7Q37369370-73A2E7F4-DBBD-4D56-B658-36970A390F13Q37525543-94F24101-637D-47C5-B9D0-5DCE185BBAE2Q37624578-0691941E-A15E-4073-BDB3-1945B8B94331Q37908437-49B37A13-6574-4775-B56C-6BF5E5796BCAQ38308192-266701F7-CFB8-47C3-9687-733DC02C0A5FQ38311113-AE27775A-BCFA-4438-A6D6-569E6D501448Q38604042-7CD3C23B-0304-4D3A-A730-C56D5D1D6136Q39152557-2FCD75A5-6367-4BE7-8F95-BF877FF9E44BQ39929451-EE606F39-C42B-41E1-A7C8-5E974DBA601FQ40408766-F02BD111-6BFA-40F3-B400-36B17BF24BEBQ40556204-16958989-18C8-41FC-9FEF-8BFE9BD9F897Q40565739-C8CD0CD6-5B33-4A2C-9458-2D7F283DA12DQ41345743-9D44868D-BE3E-4EE6-8C00-69183C0BF3BAQ41643992-71665422-03DD-4E1E-B155-83C36843BD8BQ43561180-0C6EF3C9-1306-45EF-81F8-F0F3E01048A9Q44189640-38ED5168-E53A-415E-AA36-F0FC1C617CCAQ45771083-BB3F3F1C-4746-443E-B711-5A21C7DDCCFFQ50642978-3E568167-B13E-4D71-B06B-B774ADFE7F99Q50975433-A3C95837-6AAE-4F56-9D48-9F517809A530Q51013890-92A3F534-85B1-402A-9987-C3DE77555DCE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Matthias Edinger
@ast
Matthias Edinger
@en
Matthias Edinger
@es
Matthias Edinger
@nl
Matthias Edinger
@sl
type
label
Matthias Edinger
@ast
Matthias Edinger
@en
Matthias Edinger
@es
Matthias Edinger
@nl
Matthias Edinger
@sl
prefLabel
Matthias Edinger
@ast
Matthias Edinger
@en
Matthias Edinger
@es
Matthias Edinger
@nl
Matthias Edinger
@sl
P106
P1153
7003799633
P21
P31
P496
0000-0003-2889-2533